Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements [Yahoo! Finance]
Co-Diagnostics, Inc. (CODX)
US:NASDAQ Investor Relations:
ir.codiagnostics.com/investor-relations
Company Research
Source: Yahoo! Finance
SALT LAKE CITY March 10, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that on March 9, 2026, the Company received formal notice from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price rule. As a result, the previously disclosed listing matter has been closed and the Company's shares will resume trading on Nasdaq effective March 11, 2026. (PRNewsfoto/Co-Diagnostics) Co-Dx believes that regaining Nasdaq compliance enhances the Company's capital markets flexibility and provides confidence to shareholders, while the Company continues to focus on completing clinical performance studies and regulatory clearance pathways that will allow the Company to bring the Co-Dx PC
Show less
Read more
Impact Snapshot
Event Time:
CODX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CODX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CODX alerts
High impacting Co-Diagnostics, Inc. news events
Weekly update
A roundup of the hottest topics
CODX
News
- Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies [Yahoo! Finance]Yahoo! Finance
- Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform TechnologiesPR Newswire
- Co-Diagnostics Regains Compliance with Nasdaq Listing RequirementsPR Newswire
- Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs DubaiPR Newswire
- Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ InstrumentPR Newswire
CODX
Earnings
- 11/13/25 - Beat
CODX
Sec Filings
- 3/10/26 - Form 8-K
- 2/11/26 - Form SCHEDULE
- 1/21/26 - Form S-8
- CODX's page on the SEC website